Protego Biopharma, Inc. — Form D
Protego Biopharma, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-12-17. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-12-17
- Form: D
- Accession: 0001796909-19-000001
- Industry: Biotechnology
- Exemptions: 04, 06b, 4a5
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 3
- Date of first sale: 2019-12-06
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-355671
Issuer
- Name: Protego Biopharma, Inc.
- CIK: 0001796909
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 10945 VISTA SORRENTO PARKWAY, SUITE 150, SAN DIEGO, CA, 92130
- Phone: (858) 355-9290
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Edward W Hurwitz | Director | Brisbane, CA |
| XIN JIANG | Executive Officer | San diego, CA |
| Jeffery W Kelly | Promoter | La Jolla, CA |
| Shelley Chu | Director | Lexington, MA |
| TIM J LOHOFF | Director | SAN DIEGO, CA |
| HANK MICHAEL PETRASSI | Executive Officer | SAN DIEGO, CA |
| JANWILLEM J NAESENS | Director | SAN DIEGO, CA |
| SAOUSSEN J BEN HALIMA | Director | SAN DIEGO, CA |
| LAURA J BRASS | Director | SAN DIEGO, CA |
| JEFFERY J KELLY | Director | SAN DIEGO, CA |
| Brent J Warner | Director | SAN DIEGO, CA |
| Brent J Warner | Executive Officer | SAN DIEGO, CA |
| SHELLEY J CHU | Director | SAN DIEGO, CA |
| Jeffrey Kelly | Director | Concord, NC |
| Richard Labaudiniere | Director | San Diego, CA |
| Richard Labaudiniere | Executive Officer | San Diego, CA |
| Edward Hurwitz | Director | San Diego, CA |
| Helen Kim | Director | San Diego, CA |
| Edward J Hurwitz | Director | Menlo Park, CA |
| Helen J Kim | Director | Menlo Park, CA |
Other filings by this issuer (2)
More